A new simulation-based analysis from Rutgers Health suggests that a federal nicotine reduction standard could dramatically cut tobacco harm—especially for people living with major depression—while delivering large economic gains.
The study, published in Tobacco Control, evaluates the FDA’s proposed product standard to cap nicotine in combusted cigarettes at minimally or nonaddictive levels. While a typical cigarette contains about 10 to 14 milligrams of nicotine, the proposal would set the limit at 0.7 milligrams.
Because nicotine is the core driver of addiction, lowering nicotine exposure may reduce initiation and make quitting more achievable. The researchers focused on major depression, a group that experiences smoking at disproportionately higher rates than the general population, and for whom smoking can intensify depressive symptoms.
Using a computational forecasting model, the team projected long-term health and financial outcomes for the U.S. population through 2100. The model tracks how individuals transition between health and substance-use states over time, starting with people born without major depression or smoking history.
To estimate real-world impacts, the authors scaled results to U.S. costs and prevalence using data sources including the Medical Expenditure Panel Survey and the National Survey on Drug Use and Health. This allowed the simulation to translate changes in smoking behavior into measurable mortality prevention, disease burden, and downstream productivity effects.
Results indicate that the policy could drive smoking rates below 1% across population groups by 2040. For individuals with and without major depression, the model projects near elimination of smoking by that horizon, with sustained effects into later decades.
By 2100, the researchers estimate the policy could prevent 1.6 million premature deaths and reduce the number of people who develop major depression by 8 million. The model also suggests that altered tobacco exposure would ripple through public health outcomes over decades.
From an economic perspective, reduced smoking is projected to boost worker productivity by $298 billion and increase consumer spending by $1.3 trillion. The mechanism is straightforward in the model: fewer early deaths translate into more years of work and consumption.
While a federal mandate is uncertain, the researchers argue that states and localities could act now through sales restrictions, similar to existing approaches used for flavored products. Their findings are made explorable through an online interactive policy tool designed to support decision-making.
Subject of Research: People
Article Title:
News Publication Date: 15-Jul-2026
Web References: https://doi.org/10.1136/tc-2025-059896
References: FDA proposed product standard (nicotine cap); Tobacco Control Policy Tool; Medical Expenditure Panel Survey; National Survey on Drug Use and Health
Image Credits:
Keywords: nicotine reduction, combusted cigarettes, major depression, tobacco control, computational simulation, public health disparity, smoking prevalence, FDA standard, productivity
